[go: up one dir, main page]

US2890973A - Treating tobacco and cigarette paper - Google Patents

Treating tobacco and cigarette paper Download PDF

Info

Publication number
US2890973A
US2890973A US716117A US71611758A US2890973A US 2890973 A US2890973 A US 2890973A US 716117 A US716117 A US 716117A US 71611758 A US71611758 A US 71611758A US 2890973 A US2890973 A US 2890973A
Authority
US
United States
Prior art keywords
acid
tobacco
cozymase
smoking
yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US716117A
Inventor
Fachini Giuseppe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US2890973A publication Critical patent/US2890973A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H5/00Special paper or cardboard not otherwise provided for
    • D21H5/12Special paper or cardboard not otherwise provided for characterised by the use of special fibrous materials
    • D21H5/14Special paper or cardboard not otherwise provided for characterised by the use of special fibrous materials of cellulose fibres only
    • D21H5/16Tobacco or cigarette paper
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/20Biochemical treatment
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/282Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by indirect addition of the chemical substances, e.g. in the wrapper, in the case
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances

Definitions

  • the smoke from the cigarette, cigar or the like should be admixed generally with at least one body or compound adapted to intervene into the cellular metabolism of human organism, more particularly into the cellular respiratory process.
  • bodies or compounds are for instance vitamin B, vitamin PP (known as nicotinic acid or betapyridin-carboxylic acid), vitamin C, adenylic acid and pantothenic acid, as well as ferments and co-ferments.
  • the ratio of betapyridincarboxylic acid to adenosinetriphosphoric acid should" range between about 10:1 and 10:4, it being understood.
  • a typical composition according to this invention is as follows:
  • Smoking was started when cutaneous temperatures were 7 stabilized, viz., when variations thereof were less than 0.1 C. Determination of the temperature was carried out every minute for a total time of at least fifteen minutes running from the start of smoking The vertical line 'A corresponding to 4.5 min. indicates when smoking was: i
  • Curve B refers to the batch 1 (untreated cigarett'esL" It appears from this curve that in about six minutes after smoking was started cutaneous temperature was subjected to A C. decrease of 1.14 C., thereafter it beganincreasing andithen stabilized to its initial value after more than sixteen minutes from the moment the smoking' was if started.
  • Curve C refers to cigarettes treated with nicotinic acid only (batch 2). i The maximum decrease in temperature was in this case 076 C. only and temperature stabilized to'its normal valueafter about sixteen minutes.
  • Curve D refers to cigarettes of batch 6, that -is to cigarettesprepared according to one aspect of this inf vention. In this case, the maximum, decrease was 036 was interrupted, X Curve E refers to cigarettes of batch 15.
  • Curve F refers to a cigarette from batch 10, which differs from batch 6 in that while in the latter 0.5 mg. sodium adenosinetriphosphate were employed, in the former 0.5 mg. adenylic acid were employed. Though curve F is more favourable for instance than curve C (nicotinic acid only), it will however be seen that it does not reach the advantage shown by curve D. This shows that adenylic acid cannot be looked upon as an equivalent of adenosinetriphosphoric acid (which evolves on decomposition of sodium adenosine triphosphate).
  • this invention is based on a novel association of at least two components (nicotinic acid and adenosinetriphosphoric acid), preferably in combination with cozymase or cozymase II, in certain proportions to one another and .to tobacco such as to yield a synergetic action not obtainable with yeast only (compare batches 13-15 and curve E on the diagram), in any case superior to the action of nicotinic acid in association with adenylic acid (batch 9).
  • the individual components should be separately available for duly proportioning thereof.
  • a mixture of 0.5-30 parts by weight nicotinic acid (betapyridincarboxylic acid) and 0.5- parts by weight adenosinetriphosphoric acid (or sodium adenosine triphosphate) is separately prepared, adding, if needed, 0.1-1 part by weight cozymase I or II, this mixture being uniformly distributed over 1,000 parts by weight tobacco.
  • nicotinic acid betapyridincarboxylic acid
  • adenosinetriphosphoric acid or sodium adenosine triphosphate
  • yeast which, as is well known, contains less than 0.05% cozymase I and similar irrelevant contents of nicotinic acid and adenosinetriphosphoric acid.
  • Physical manipulation of the individual ingredients and tobacco for the purpose of thorough mixing, uniform distribution or impregnation is no problem per se and can be carried out in the usual manner in this branch, such as indicated by Steiner or Hicks.
  • a neutralizing agent consisting of at least 0.5 mg. of betapyridincarboxylic acid, and at least 0.5 mg. of a compound selected from the group consisting of adenosine ltriphosphoric acid and sodium adenosine triphosphate per every gram of tobacco contained in the preparation.
  • a neutralizing agent consisting of at least 0.5 mg. of betapyridincarboXylic acid, at least 0.5 mg. of a compound selected from the group consisting of adenosine triphosphoric acid and sodium adenosine triphosphate, and at least 0.1 mg. of an enzyme selected from the group consisting of cozymase I and cozymase II per every gram of the tobacco contained in the preparation.
  • a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, and about 0.5 mg. sodium adenosine triphosphate per every gram of the tobacco contained in the preparation.
  • a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, about 0.5 mg. sodium adenosine tr-iphosphate, and at least 0.1 mg. cozymase II per every gram of tobacco contained in the preparation.
  • a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, about 0.5 mg. adenosine triphosphoric acid, and at least 0.1 mg. cozymase II per every gram of tobacco contained in the preparation.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Manufacture Of Tobacco Products (AREA)

Description

June 1959 G. FACHINI TREATING TOBACCO AND CIGARETTE PAPER Filed Feb. 19, 1958 United States Paten 2,890,973 TREATING TOBACCO AND CIGARETTE PAPER Giuseppe Fachini, Milan, Italy Application February 19, 1958, Serial No. 716,117 Claims priority, application Italy March 3, 1954 5 Claims. Cl. 131-47 This invention relates to tobacco preparations for smoking and aims generally to neutralise toxic and cancerogenicefiects of tobacco.
Attempts have been made for a long time to treat tobacco or cigarette paper with a view to neutralizing or at least reducing toxic elfects of smoke inspired by smokers. So, for instance U.S. Patent 1,842,266 to Calvin S. Hicks suggests to admix tobacco with a proportion of yeast (OBI-%). This prior proposal is based on the acknowledgment that the effects of smoke on human organism are the same as or similar to those produced by the deficiency of vitamin B, more particularly depression of growth, depression of the physiological system, autointoxication, loss of appetite, dyspepsia, intestinal stasis or stoppage, disruption of neuro-muscular control and general lowering of vitality and ability to ward 01f infection. Since, as is well known, yeast is a product relatively rich in vitamin B, Hicks exactly proposes to admix tobacco blend with yeast, so that vitamin B can be inspired by the smoker and absorbed by the organism for neutralizing the above toxic efiects.
A more recent work in this field is due to Pierre Steiner (French Patent No. 932,560, published on March 25, 1948). According to Steiner, the smoke from the cigarette, cigar or the like should be admixed generally with at least one body or compound adapted to intervene into the cellular metabolism of human organism, more particularly into the cellular respiratory process. These bodies or compounds are for instance vitamin B, vitamin PP (known as nicotinic acid or betapyridin-carboxylic acid), vitamin C, adenylic acid and pantothenic acid, as well as ferments and co-ferments.
In experiments, which have preceded my invention I ascertained that the discoveries by Hicks and Steiner actually involve improvements in reaction against smoke by the human organism, consisting more particularly in a smaller lowering of cutaneous temperature upon smoking a cigarette, as well as in more rapid restoring to normal temperature.
It should however be added now that, according to more recent scientific opinions, objectionable smoke ef fects are due prevailingly to tar substances generated on combustion of tobacco, said substances when inspired by the smoke being responsible not only for most of the above mentioned intoxication symptoms, but also above all, of some forms of cancer, such as lung cancer. Therefore in determining the useful efifects of neutralizing agents such as yeast, nicotinic acid etc. a fundamental importance should be attributed to the contents of tar substances in thesmoke from cigarettes which have been admixed with such agents. Unfortunately as will be explained in greater detail hereafter, neutralizing agents proposed heretofore are incapable of substantially and appreciably reducing said content. So, for instance, combustion of one gram tobacco of cigarettes known in Italy by the brand Nazionali yields about 0.047 gram of tar substances. Combustion of one gram of the same to- 10 mg. of brewers yeast yields about 0.041 gram of tar substances. These contents are further lowered when adding 100 mg. of yeast. However, in the latter case, the cigarettetaste is however fully altered, while the reduction in tar substance content does not reach even 20% with respect to the original value.
Nicotinic acid (betapyridincarboxylic acid) has been found more advantageous under this aspect as a proportion of 0.05% of said acid reduces the tar substances content to a value of about 0.036 gram per gram of tobacco and, when added in relatively high proportions (50 mg./=g.) which are not always cheap, said content is lowered down to 0.024 gram (about a half of the original content).
These results cannot be regarded as satisfactory both because they require an excessive proportion of neutral izing agents and-because a reduction down to 50% of the tar substances content can be reached even through suitable filters, which are considerably less expensive and do not alter the cigarette taste.
Now inconsiden'ng these results obtainable heretofore I conceived that better results could be reached if a neutralizing agent could be built .up comprising at least two components, one of which should exert a synergetic action inrespect of the other. It should be noted that this concept of the synergetic action is thoroughly novel in this field, inasmuch as, contrarily to the proposals by Steiner or Hicks, it is not based on the choice of one or other compound merely because it contains a vitamin or an enzyme, but involves a combination of at least two compounds Which, by acting jointly, yield immediate results (substantial reduction in tar substances content) beyond any expectation.
Startingfrom this idea I have found that the neutralizing efiect due. to betapyridincarboxylic acid becomes highly appreciable if this acid be accompanied by the adenosinetriphosphoricacid or a salt of the latter which, by decomposing, exactly yields adenosinetriphosphoric acid. Such salt could be more particularly sodium adenosinetriphosphate. Moreover, I further ascertained that further improved results are obtained by adding to the two abovementioned components (betapyridincarboxylic and adenosinetriphosphoric acid) a coenzyme selected from the group consisting of cozymase I and cozymase II.
This application is a continuation-in-part of my application Serial No. 491,545, filed March 1, 1955, now abandoned.
It should be noted at this stage that all these com ponents are to-be found in yeast which, however, also and prevailingly contains numerous further components have found it important for the relative proportions of baccosblend which has, however, beenadmixed with said componentsto be maintained above certain minimum values. A So,- for instance, for the synergetic action to develop fully and in order. to attain ,a maximum reduction in tar substances there should be to. each gramtobacco 05-30 mg. (0.054%) betapyridincarboxylic acid (nicotinic acid) and 0.5-5 mg. (0.040.5%) adenosinetriphosphoric acid or its abovementioned sodium salt possibly with at least 0.1-1 mg. (0.01-0.1%') cozymase I or cozymase II. Greater importance should be attributed to lower limits for, if desired, top limits can be exceeded which is, however, detrimental to thecigarette:
taste and economy, since proportions exceeding those indicated above do not lead to appreciable further improvements. Moreover, generally, the ratio of betapyridincarboxylic acid to adenosinetriphosphoric acid should" range between about 10:1 and 10:4, it being understood.
that in the presence of cozymase I or cozymase II the proportion of adenosinetriphosphoric acid should be displaced towards its lower limit.
A typical composition according to this invention is as follows:
Tobacco 1.0 g. Nicotinic acid mg. (0.5%) Sodium adenosinetriphosphate 0.5 mg. (0.05%)
the percentages being by weight and being referred to the tobacco quantity. i
The effects obtained by this invention can be looked upon as surprising in respect of the tar substances content and lowering of the cutaneous temperature during smoking and after smoking, as will be better explained hereafter. From tobacco composing the cigarettes of the brand Nazionali seventeen different batches were prepared, numbered 1 to 17 in the following table, of the composition given in the table. From each batch 100 cigarettes were manufactured, which were smoked in an apparatus comprising a mouthpiece connected with a suction pump through a number of Drechsel (bubbling) bottles followed by a Liebig cooler. Each Drechsel bottle contained 50 ml. chloroform which is known as an elective solvent for tar substances. With an apparatus prepared as above, a cigarette is inserted into the mouthpiece, suction by the pump is adjusted to be, as Will be ascertained from the extent of bubbling, rather moderate and uniform, the cigarette being then lit. Under these conditions the tar substances evolved on combustion of tobacco are absorbed by chloroform and any non-absorbed proportion are condensed in the Liebig cooler. Upon smoking synergetic action. It will therefore be obvious that use of yeast as neutralizing agent could be justified by its vitamin B content but is not connected in the least with the spirit and scope of this invention. So, for instance, yeast probably exerts on the human organism delayed actions, connected with its vitaminic contents as well as a certain action which somewhat reduces the usual lowering of the cutaneous'temperature, as will be explained in greater than preventive properties.
ined on separately considering batches 2 and 16. It is further pointed out that the result yieldedby batch 6 or 11 or 12 is undoubtedly surprising over the result yielded bybatches' such as 7 or 10 which lacked adenosinetri phosphoric acid, which is the chief synergetic agent acthe 100 cigarettes of one batch, the apparatus is disassembled, all its component parts are Washed with chloroform in order to collect any trace of tar substances, the whole chloroform containing the tar substances being evaporated on a boiling water bath. The tar residue is I weighed, the resulting weight being divided by the weight of the burnt tobacco. This yields the weight of tar sub-.
stances referred to one gram tobacco from the batch,
The same procedure was followed with further 16 batches, the results being as follows:
' Tar con- Batch No. Composition referred to 1 g. of tobacco tent per g. o tobacco G. not treated a 0. 04733 5 mg. nicotinic acid. 0.03587 50 mg. nicotinic acid... 0.02352 {5 mg. nicotinic acid 0 01321 0.5 mg. sodium adenosine triphosphate {5 mg. nicotinic acid... 0 01296 2 mg. sodium adenosine triphospha 5 mg. nicotinic acid 0.5 mg. sodium adenosine triphosphate 0.01271 1 mg. Oozymase 0. 02783 0. 01063 0. 02662 0.02317 {0.5 mg. sodium aderio me 0.01295 1 mg. Cozymase I 5 mg. nicotinic acid 12 0.5 mg. adencsine triphosphoric acid 0. 01214 The above table (batches 1, 13, 14, 15) shows first of all that the admixture of yeast, even in considerable proportions, leaves the tar substances content practically unaffected. This may be explained by the fact that nicotinic acid, adenosinetriphosphorie acid and cozymase are found in yeast in negligible proportions for practical use and are probably not in a condition suitable to promote a cordingto this invention.
The best results were yielded by batches 5, 6, 11 and 12 f in which the tar substances content was reduced to about 0.012 g. per grain of tobacco through an addition of neutralizing agents which does not exceed 7 mg. The result yielded by batch 8 can be looked upon as exceptional, l
but has beeniobtained through larger proportions of neufore unacceptable.
Reference will hereafter be made to the accompanying 7 drawing, showing adiagram on which the abscissae give in minutes and the ordinates the drop A C. intemperature. The curves plotted on this diagramweredetermined by experiments on human subjects, each curve showing the average of the results of 44 tests.
Each time a cigarette was smoked by a subject in four employed for measuring cutaneous temperature.
Smoking was started when cutaneous temperatures were 7 stabilized, viz., when variations thereof were less than 0.1 C. Determination of the temperature was carried out every minute for a total time of at least fifteen minutes running from the start of smoking The vertical line 'A corresponding to 4.5 min. indicates when smoking was: i
interrupted.
' Curve B refers to the batch 1 (untreated cigarett'esL" It appears from this curve that in about six minutes after smoking was started cutaneous temperature was subjected to A C. decrease of 1.14 C., thereafter it beganincreasing andithen stabilized to its initial value after more than sixteen minutes from the moment the smoking' was if started.
Curve C refers to cigarettes treated with nicotinic acid only (batch 2). i The maximum decrease in temperature was in this case 076 C. only and temperature stabilized to'its normal valueafter about sixteen minutes.
Curve D refers to cigarettes of batch 6, that -is to cigarettesprepared according to one aspect of this inf vention. In this case, the maximum, decrease was 036 was interrupted, X Curve E refers to cigarettes of batch 15.
. In comparisonwith curve B, this curve E denotes. a certain improvement in the sense that decrease in tem-' perature was 0.81 C. only (instead of 1.'14 C.) and temperatureistabilized more quickly.. However,'the subjects all complained about astrange taste of the ciga .5 fettes which, on the other hand, was not at all surprising, since each cigarette contained 10% yeast.
Curve F refers to a cigarette from batch 10, which differs from batch 6 in that while in the latter 0.5 mg. sodium adenosinetriphosphate were employed, in the former 0.5 mg. adenylic acid were employed. Though curve F is more favourable for instance than curve C (nicotinic acid only), it will however be seen that it does not reach the advantage shown by curve D. This shows that adenylic acid cannot be looked upon as an equivalent of adenosinetriphosphoric acid (which evolves on decomposition of sodium adenosine triphosphate).
Considering the preceding description, it is believed that experts the branch are now in a condition to fully appreciate the spirit and scope of this invention, as well as the diiferences between this invention and teachings of the prior art. More particularly, as shown by the preceding table and diagram on the accompanying drawing, this invention is based on a novel association of at least two components (nicotinic acid and adenosinetriphosphoric acid), preferably in combination with cozymase or cozymase II, in certain proportions to one another and .to tobacco such as to yield a synergetic action not obtainable with yeast only (compare batches 13-15 and curve E on the diagram), in any case superior to the action of nicotinic acid in association with adenylic acid (batch 9). This leads to believe that, while adenylic acid chiefly acts on the subject and affects combustion by a small extent only, as distinct therefrom, adenosinetriphosphoric acid besides positively affecting the subject moreover gives rise to decomposition products which co act with nicotinic acid in strongly afiecting in a negative sense building up of tar substances, thereby preventing at the start possible eifects on the human organism.
It will be moreover understood that, in order to carry out the invention, the individual components should be separately available for duly proportioning thereof. Generally, a mixture of 0.5-30 parts by weight nicotinic acid (betapyridincarboxylic acid) and 0.5- parts by weight adenosinetriphosphoric acid (or sodium adenosine triphosphate) is separately prepared, adding, if needed, 0.1-1 part by weight cozymase I or II, this mixture being uniformly distributed over 1,000 parts by weight tobacco. However, it is pointed out that, since the proportion of the agents according to this invention with respect to tobacco is generally significantly small, these agents can even be jointly incorporated for instance in cigarette 6. paper or any component of the cigarette or cigar taking part in combustion. This would not be possible with yeast which, as is well known, contains less than 0.05% cozymase I and similar irrelevant contents of nicotinic acid and adenosinetriphosphoric acid. Physical manipulation of the individual ingredients and tobacco for the purpose of thorough mixing, uniform distribution or impregnation is no problem per se and can be carried out in the usual manner in this branch, such as indicated by Steiner or Hicks.
What I claim is:
1. In a smoking preparation of tobacco, a neutralizing agent consisting of at least 0.5 mg. of betapyridincarboxylic acid, and at least 0.5 mg. of a compound selected from the group consisting of adenosine ltriphosphoric acid and sodium adenosine triphosphate per every gram of tobacco contained in the preparation.
2. In a smoking preparation of tobacco, a neutralizing agent consisting of at least 0.5 mg. of betapyridincarboXylic acid, at least 0.5 mg. of a compound selected from the group consisting of adenosine triphosphoric acid and sodium adenosine triphosphate, and at least 0.1 mg. of an enzyme selected from the group consisting of cozymase I and cozymase II per every gram of the tobacco contained in the preparation.
3. In a smoking preparation of tobacco, a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, and about 0.5 mg. sodium adenosine triphosphate per every gram of the tobacco contained in the preparation.
4. In a smoking preparation of tobacco, a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, about 0.5 mg. sodium adenosine tr-iphosphate, and at least 0.1 mg. cozymase II per every gram of tobacco contained in the preparation.
5. In a smoking preparation of tobacco, a neutralizing agent consisting of about 5 mg. betapyridincarboxylic acid, about 0.5 mg. adenosine triphosphoric acid, and at least 0.1 mg. cozymase II per every gram of tobacco contained in the preparation.
References Cited in the file of this patent FOREIGN PATENTS

Claims (1)

1. IN A SMOKING PREPARATION OF TOBACCO, A NEUTRALIZING AGENT CONSISTING OF AT LEAST 0.5 MG. OF BETAPYRIDINCARBOXYLIC ACID, AND AT LEAST 0.5 MG. OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF ADENOSINE TRIPHOSPHORIC
US716117A 1954-03-03 1958-02-19 Treating tobacco and cigarette paper Expired - Lifetime US2890973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2890973X 1954-03-03

Publications (1)

Publication Number Publication Date
US2890973A true US2890973A (en) 1959-06-16

Family

ID=11436212

Family Applications (1)

Application Number Title Priority Date Filing Date
US716117A Expired - Lifetime US2890973A (en) 1954-03-03 1958-02-19 Treating tobacco and cigarette paper

Country Status (1)

Country Link
US (1) US2890973A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043723A (en) * 1959-09-17 1962-07-10 Gen Cigar Co Process and product utilizing tobacco stems
US3339558A (en) * 1966-10-28 1967-09-05 Haskett Barry F Smoking article and filter therefor containing vitamin a
US3844294A (en) * 1970-03-23 1974-10-29 Ici Ltd Tobacco substitute smoking mixture
EP0116085A4 (en) * 1982-08-05 1984-11-16 William Alvin Carter INTERFERON AND INTERFERON INDUCERS COMBINED WITH TOBACCO PRODUCTS.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR932560A (en) * 1944-06-20 1948-03-25 Device usable in the consumption of tobacco by combustion
FR932561A (en) * 1944-05-31 1948-03-25 Tobacco

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR932561A (en) * 1944-05-31 1948-03-25 Tobacco
FR932560A (en) * 1944-06-20 1948-03-25 Device usable in the consumption of tobacco by combustion

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043723A (en) * 1959-09-17 1962-07-10 Gen Cigar Co Process and product utilizing tobacco stems
US3339558A (en) * 1966-10-28 1967-09-05 Haskett Barry F Smoking article and filter therefor containing vitamin a
US3844294A (en) * 1970-03-23 1974-10-29 Ici Ltd Tobacco substitute smoking mixture
EP0116085A4 (en) * 1982-08-05 1984-11-16 William Alvin Carter INTERFERON AND INTERFERON INDUCERS COMBINED WITH TOBACCO PRODUCTS.

Similar Documents

Publication Publication Date Title
US3385303A (en) Reconstituted tobacco product
US4694842A (en) Tea-containing tobacco
US4489739A (en) Smokable tobacco composition and method of making
US5326563A (en) Nicotine compositions
JP3145702B2 (en) Smoking composition
US3722516A (en) Smoking tobacco product and method of making the same
CN110810887A (en) Processing method of burley tobacco
CN103445288A (en) Processing method for increasing usability of burley tobacco
WO1987006104A1 (en) Improvements in and relating to tobacco products
DE2356706A1 (en) SMOKE MIXTURES
US2890973A (en) Treating tobacco and cigarette paper
US2171986A (en) Paper and paper making
CA2803587A1 (en) Cellulosic material such as tobacco comprising one or more smoke diluents
US1842266A (en) Toracco mixture
CN111602838A (en) Feed liquid for increasing scorched and sweet aroma of tobacco leaves and method for treating tobacco leaves
KR900007855B1 (en) Process for making cigarettes from leaf of eucommia ulmoides oliver
US3085581A (en) Process of treating tobacco and the resultant product
US2460285A (en) Tobacco products and method of making them
US4600026A (en) Tobacco composition with bluish dogbane and a process for the preparation thereof
Gala et al. Influence of neurohumors on anterior pituitary lactogen production in vitro.
CN1100610A (en) Cigarette made of tobacco substitutes
US3251368A (en) Method of treating tobacco to improve its smoking properties and ash colour
US2331830A (en) Tobacco
WO1999020131A1 (en) A cigarette of ginkgo leaves
US729218A (en) Process of improving tobacco.